214 related articles for article (PubMed ID: 8732705)
1. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
Yokoyama H; Jensen JS; Myrup B; Mathiesen ER; Rønn B; Deckert T
Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
[TBL] [Abstract][Full Text] [Related]
2. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
Crook MA; Earle K; Morocutti A; Yip J; Viberti G; Pickup JC
Diabetes Care; 1994 Apr; 17(4):305-10. PubMed ID: 8026286
[TBL] [Abstract][Full Text] [Related]
3. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
[TBL] [Abstract][Full Text] [Related]
4. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Yokoyama H; Jensen JS; Jensen T; Deckert T
J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
[TBL] [Abstract][Full Text] [Related]
5. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
[TBL] [Abstract][Full Text] [Related]
6. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
[TBL] [Abstract][Full Text] [Related]
7. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
[TBL] [Abstract][Full Text] [Related]
8. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
Rudberg S; Persson B
Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor and development of diabetic nephropathy in IDDM.
Stehouwer CD; Stroes ES; Hackeng WH; Mulder PG; Den Ottolander GJ
Diabetes; 1991 Aug; 40(8):971-6. PubMed ID: 1907250
[TBL] [Abstract][Full Text] [Related]
11. Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitus.
Myrup B; Mathiesen ER; Rønn B; Deckert T
Diabetes Res; 1994; 26(1):33-9. PubMed ID: 7664535
[TBL] [Abstract][Full Text] [Related]
12. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
Bulum T; Duvnjak L; Prkacin I
Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
[TBL] [Abstract][Full Text] [Related]
13. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria.
Santilli F; Spagnoli A; Mohn A; Tumini S; Verrotti A; Cipollone F; Mezzetti A; Chiarelli F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3871-6. PubMed ID: 11502826
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of microalbuminuria in young Italian insulin-dependent diabetic patients with short duration of disease: a population-based study. Piedmont Study Group for Diabetes Epidemiology.
Bruno G; Pagano G
Diabet Med; 1996 Oct; 13(10):889-93. PubMed ID: 8911783
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
[TBL] [Abstract][Full Text] [Related]
16. Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients.
O'Brien SF; Watts GF; Powrie JK; Shaw KM
Diabetes Care; 1995 Dec; 18(12):1602-5. PubMed ID: 8722059
[TBL] [Abstract][Full Text] [Related]
17. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
18. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
[TBL] [Abstract][Full Text] [Related]
19. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus.
Deinum J; Rønn B; Mathiesen E; Derkx FH; Hop WC; Schalekamp MA
Diabetologia; 1999 Aug; 42(8):1006-10. PubMed ID: 10491762
[TBL] [Abstract][Full Text] [Related]
20. [Microalbuminuria as predictor of atherosclerotic cardiovascular disease in IDDM].
Deckert T; Yokoyama H; Mathiesen ER; Rønn B; Jensen TJ; Feldt-Rasmussen BF; Borch-Johnsen K; Jensen JS
Ugeskr Laeger; 1997 May; 159(20):3010-4. PubMed ID: 9190730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
